Cytek Biosciences, Inc. (CTKB) Misses Q3 EPS by 1c, Beats on Revenue

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $52.3 million versus the consensus estimate of $51.03 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
• John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance
• Ciena beats estimates on strong AI-driven demand, shares rise